Quantitative Expression of Key Cancer Markers in the AS-30D Hepatocarcinoma Model
- PMID: 34737944
- PMCID: PMC8561839
- DOI: 10.3389/fonc.2021.670292
Quantitative Expression of Key Cancer Markers in the AS-30D Hepatocarcinoma Model
Abstract
Hepatocellular carcinoma is one of the cancers with the highest mortality rate worldwide. HCC is often diagnosed when the disease is already in an advanced stage, making the discovery and implementation of biomarkers for the disease a critical aim in cancer research. In this study, we aim to quantify the transcript levels of key signaling molecules relevant to different pathways known to participate in tumorigenesis, with special emphasis on those related to cancer hallmarks and epithelial-mesenchymal transition, using as a model the murine transplantable hepatocarcinoma AS-30D. Using qPCR to quantify the mRNA levels of genes involved in tumorigenesis, we found elevated levels for Tgfb1 and Spp1, two master regulators of EMT. A mesenchymal signature profile for AS-30D cells is also supported by the overexpression of genes encoding for molecules known to be associated to aggressiveness and metastatic phenotypes such as Foxm1, C-met, and Inppl1. This study supports the use of the AS-30D cells as an efficient and cost-effective model to study gene expression changes in HCC, especially those associated with the EMT process.
Keywords: AS-30D cells; AS30D model; Spp1; cancer markers; epithelial-mesenchymal transition; hepatocellular carcinoma; osteopontin.
Copyright © 2021 Briones-Orta, Delgado-Coello, Gutiérrez-Vidal, Sosa-Garrocho, Macías-Silva and Mas-Oliva.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AZH declared a shared affiliation, with several of the authors, BDC, RGV, MSG, MMS, JMO, to the handling editor at the time of the review.
Figures
Similar articles
-
Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.Front Oncol. 2021 May 25;11:690800. doi: 10.3389/fonc.2021.690800. eCollection 2021. Front Oncol. 2021. PMID: 34113574 Free PMC article. Review.
-
Role of epithelial to mesenchymal transition in hepatocellular carcinoma.J Hepatol. 2016 Oct;65(4):798-808. doi: 10.1016/j.jhep.2016.05.007. Epub 2016 May 17. J Hepatol. 2016. PMID: 27212245 Review.
-
TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells.J Exp Clin Cancer Res. 2016 May 4;35:72. doi: 10.1186/s13046-016-0350-y. J Exp Clin Cancer Res. 2016. PMID: 27141829 Free PMC article.
-
miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.Int J Gynecol Cancer. 2015 Nov;25(9):1574-81. doi: 10.1097/IGC.0000000000000546. Int J Gynecol Cancer. 2015. PMID: 26501435
-
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196. World J Gastroenterol. 2015. PMID: 25574092 Free PMC article.
Cited by
-
Analysis of cholesterol-recognition motifs of the plasma membrane Ca2+-ATPase.J Bioenerg Biomembr. 2024 Jun;56(3):205-219. doi: 10.1007/s10863-024-10010-5. Epub 2024 Mar 4. J Bioenerg Biomembr. 2024. PMID: 38436904 Free PMC article.
References
-
- Smith DF, Walborg EF, Jr, Chang JP. Establishment of a Transplantable Ascites Variant of a Rat Hepatoma Induced by 3’-Methyl-1-4-Dimethylaminoazobenzene. Cancer Res (1970) 30:2306–09. - PubMed
-
- Thompson SM, Callstrom MR, Knudsen B, Anderson JL, Butters KA, Grande JP, et al. . AS30D Model of Hepatocellular Carcinoma: Tumorigenicity and Preliminary Characterization by Imaging, Histopathology, and Immunohistochemistry. Cardiovasc Intervent Radiol (2013) 36:198–203. doi: 10.1007/s00270-012-0466-1 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous